Neuropathology of transmissible spongiform encephalopathies (prion diseases)

Neurodegeneration and Prion Disease

Volumn , Issue , 2005, Pages 13-48

  Liberski, Pawel P ^a   Ironside, James W ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79551582532     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-23923-5_2     Document Type: Chapter

References (116)

1. D. C. Gajdusek, C. J. Gibbs, M. P., and Alpers M. P., Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209, 794-796 (1966).
2. C. J. Gibbs Jr, D. C. Gajdusek, D. M. Asher, M. P. Alpers, E. Beck, P. M. Daniel, and W. B. Matthews, Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to chimpanzee. Science 161, 388-389 (1968).
3. C. L. Masters, D. C, Gajdusek, and C. J. Gibbs Jr, Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome. With an analysis of the various forms of amyloid plaque deposition in the virus induced spongiform encephalopathies. Brain 104, 559-588 (1981).
4. E. Lugaresi, R. Medori, P. Montagna, A. Baruzzi, P. Cortelli, A. Lugaresi, P. Tinuper, M. Zucconi, and P. Gambetti, Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. New Engl. J. Med. 315, 997-1004 (1986).
5. D. Burger and G. R. Hartsough, A scrapie-like disease of mink, in: Report of a Scrapie Seminar (United States Department of Agriculture, paper 27, 1964), pp. 225-227.
6. P. P. Liberski, D. C. Guiroy, E. S. Williams, A. Walis, and H. Budka, Deposition patterns of disease-associated prion protein in captive mule deer brains with chronic wasting disease. Acta Neuropathol. (Berl.) 102, 496-500 (2001).
7. G. A. H. Wells, A. C. Scott, C. T. Johnson, R. F. Gunning, R. D. Hancock, M. Jeffrey, M. Dawson, and R. Bradley, A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 121, 419-420 (1987).
8. C. Weissmann, A "unified theory" of prion propagation. Nature 352, 679-683 (1991).
9. R. Gabizon, G. Telling, Z. Meiner, M. Halimi, I. Kahana, and S. B. Prusiner, Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion diseases. Nature Med., 2, 59-64 (1996).
10. B. Oesch, D. Westaway, M. Walchlii, M. P. McKinley, S. B. H. Kent, R. Aebersold, R. A. Barry, P. Tempst, D. B. Teplow, L. E. Hood, S. B. Prusiner, and C. Weissmann, A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746 (1985).
11. S. B. Prusiner, Novel proteinaceous infection particles cause scrapie. Science 216, 136-144 (1982).
12. P. P. Liberski, and M. Jaskolski, Prion diseases: a dual view of the prion hypothesis as seen from a distance. Acta Neurobiol Exp. 62, 197-226 (2002).
13. S. B. Prusiner, M. P. McKinley, K. A. Bowman, D. C. Bolton, P. E. Bendheim, D. C. Groth, and G. G. Glenner, Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349-358 (1983).
14. J. Collinge, K. C. L. Sidle, J. Meads, J. Ironside, and A. F. Hill, Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383, 685-690 (1996).
15. A. F. Hill, M. Desbruslais, S. Joiner, K. C. L. Sidle, I. Gowland, J. Collinge, L. J. Doey, and P. Lantos, The same prion strain causes vCJD and BSE. Nature 389, 448-450 (1997).
16. H. A. Kretzschmar, L. E. Stowring, D. Westaway, W. H. Stubblebine, S. B. Prusiner, and S. J. DeArmond, Molecular cloning of human prion protein cDNA. DNA, 4, 315-324 (1986).
17. S. Mead, M. P. Stumpf, J. Whitfield, J. A. Beck, M. Poulter, T. Campbell, J. B. Uphill, D. Goldstein, M. Alpers, F. M. Fisher, and J. Collinge, Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300, 640-643 (2003).
18. P. M. Daniel, Creutzfeldt-Jakob disease, J. Clin. Pathol. 25, 97-101 (1972).
19. B. Brownell and D. R. Oppenheimer, An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt-Jakob disease), J. Neurol. Neurosurg. Psychiat. 28, 350-361 (1965).
20. H. Siedler H and N. Malamud, Creutzfeldt-Jakob disease. Clinicopathological report of 15 cases and review of the literature (with special reference to a related disorder designated as subacute spongiform encephalopathy), J. Neuropathol. Exp. Neurol. 22, 381-402 (1963).
21. H. Budka, M. W. Head, J. W. Ironside, P. Gambetti, P. Parchi, M. Zeidler, and F. Tagliavini, Prion Disorders: CJD: Sporadic Creutzfeldt-Jakob disease, in Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, edited by D. Dickson (ISN Neuropath Press, Basel, 2003), pp. 287-297.
22. A. F. Hill, S. Joiner, J. D. F. Wadsworth, K. C. L. Sidle, J. E. Bell, H. Budka, J. W. Ironside, and J. Collinge, Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126, 1333-1346 (2003).
23. J. D. F. Wadsworth, A. F. Hill, S. Joiner, G. S. Jackson, A. R. Clarke, J. Collinge, Strain-specific prion-protein conformation determined by metal ions. Nature Cell Biol. 1, 55-59 (1999).
24. H. G. Creutzfeldt, Uber eine egenartige herdformige Erkrankung des Zentralnervensystems. Z. Ges. Neurol. Psychiat. 57, 1-18 (1920).
25. A. Jakob, Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde (spastische Pseudosclerose-Encephalopathie mit disseminierten Degenerationsherden). Deutsch Z. Nervenheilk. 70, 132-146 (1921).
26. A. Jakob, Spastische Pseudosclerose, in: Monographien aus dem Gesamtgebiete der Neurologie und Psychiatrie, Die Ekstrapyramidalen Erkrankungen, Vol. 37, edited by O. Foerster, K. Wilmanns (Julius Springer, Berlin, 1923), pp. 215-245.
27. C. L. Masters and D. C. Gajdusek, The spectrum of Creutzfeldt-Jakob disease and the virusinduced subacute spongiform encephalopathies, in: Recent Advances in Neuropathology, edited by T. J. Smith and J. B. Cavanagh (Churchill Livingstone, Edinburgh, 1982), pp. 139-163.
28. A. M. Salazar, C. L. Masters, D. C. Gajdusek, C. J. Gibbs Jr., Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Ann. Neurol., 14, 17-26 (1983).
29. H. Yamanouchi, H. Budka, and K. Vass, Unilateral Creutzfeldt-Jakob disease. Neurology 36, 1517-1520 (1986).
30. R. Tinter, P. Brown, T. Hedley-Whyte, E. B. Raaport, C. P. Piccardo, and D. C. Gajdusek, Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications. Neurology 36, 932-936 (1986).
31. C. L. Masters and E. P. Richardson, Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101, 333-344 (1978).
32. M. Jeffrey, J. R. Scott, A. Williams, and H. Fraser, Ultrastructural features of spongiform encephalopathy transmitted to mice from three species of bovidae. Acta Neuropathol. (Berl.) 84, 559-569 (1992).
33. S. M. Chou, W. N. Payne, C. J. Gibbs Jr., and D. C. Gajdusek, Transmission and scanning electron microscopy of spongiform change in Creutzfeldt-Jakob disease. Brain 103, 885-904 (1980).
34. P. P. Liberski, R. Yanagihara, C. J. Gibbs Jr, and D. C. Gajdusek, White matter ultrastructural pathology of experimental Creutzfeldt-Jakob disease in mice. Acta Neuropathol (Berl.) 79, 1-9 (1989).
35. P. P. Liberski, R. Kordek, P. Brown, and D. C. Gajdusek, Astrocytes in transmissible spongiform encephalopathies (prion diseases), in: Astrocytes in Brain Aging and Neurodegeneration, edited by H. M. Schipper (R. G. Landes Company, Austin, Texas, USA, 1998) pp. 127-164.
36. P. P. Liberski, P. Brown, L. Cervenakova, and D. C. Gajdusek, Interactions between astrocytes and oligodendroglia in human and experimental Creutzfeldt-Jakob disease and scrapie. Exp. Neurol. 144, 227-234 (1997).
37. M. Lafarga, M. T. Berciano, I. Suarez, C. F. Viadero, M. A. Andres, and J. Berciano, Cytology and organization of reactive astroglia in human cerebellar cortex with severe lossof granule cells: astudyontheataxic form of Creutzfeldt-Jakob disease. Neuroscience 40, 337-352 (1991).
38. M. Lafarga, M. T. Berciano, I. Suarez, M. A. Andres, and J. Berciano, Reactive astroglia-neuron relationships in the human cerebellar cortex: a quantitative, morphological and immunohistochemical study in Creutzfeldt-Jakob disease. Int. J. Dev. Neurosci. 11, 199-213 (1993).
39. M. Dubois-Dalcq, M. Rodriguez, T. S. Reese, C. J. Gibbs Jr, and D. C. Gajdusek, Search for a specific marker in the neural membranes of scrapie mice. Lab. Invest. 36, 547-553 (1977).
40. H. Budka, A. Aguzzi, P. Brown, J. M. Brucher, O. Bugiani, F. Gullotta, M. Haltia, J. J. Hauw, J. W, Ironside, K. Jellinger, et al., Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies. Brain Pathol., 4, 459-466 (1995).
41. M. Jeffrey, C. M. Goodsir, N. Fowler, J. Hope, M. E. Bruce, and P. A. McBride, Ultrastructural immuno-localization of synthetic prion protein peptide antibodies in 87V muine scrapie. Neurodegeneration 5, 101-109 (1996).
42. M. Barcikowska, P. P. Liberski, J. Boellaard, P. Brown, D. C. Gajdusek, and H. Budka, Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Sträussler-Scheinker syndrome. Acta Neuropathol. (Berl.), 85, 623-627 (1993).
43. M. Jeffrey, C. Goodsir, M. E. Bruce, P. A. McBride, and C. Farquhar, Morhogenesis of amyloid plaque in 87V murine scrapie. Neuropathol. Appl. Neurobiol. 20, 535-542 (1994).
44. J. A. Hainfellner, P. P. Liberski, D. C. Guiroy, L. Cervenakova, P. Brown, D. C. Gajdusek, and H. Budka, Pathology and immunocytochemistry of a kuru brain. Brain Pathol. 7, 547-554 (1997).
45. J. Hainfellner, S. Brantner-Inhaler, L. Cervenakova, P. Brown, T. Kitamoto, J. Tateishi, H. Diringer, P. P. Liberski, H. Regele, M. Feucht, N. Mayr, K. Wessely, K. Summer, F. Seitelberger, and H. Budka, The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol. 5, 201-213 (1995).
46. P. P. Liberski and H. Budka, Ultrastructural pathology of Gerstmann-Sträussler-Scheinker disease. Ultrastr. Pathol. 19, 23-36 (1995).
47. R. G. Will, J. W. Ironside, M. Zeidler, S. N. Cousens, K. Esstibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, and P. G. Smith PG, A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925 (1996).
48. P. P. Liberski, R. Yanagihara, C. J. Gibbs Jr., and D. C. Gajdusek, Scrapie as a model for neuroaxonal dystrophy: ultrastructural studies. Exp. Neurol. 106, 133-144 (1989).
49. P. P. Liberski, H. Budka, E. Sluga, M. Barcikowska, and H. Kwiecinski, Tubulovesicular structures in Creutzfeldt-Jakob disease. Acta Neuropathol. (Berl.) 84, 238-243 (1992).
50. P. P. Liberski and H. Budka, Neuroaxonal pathology in Creutzfeldt-Jakob disease. Acta Neuropathol. 97, 329-334 (1999).
51. J. R. Fraser, What is the basis of transmissible spongiform encephalopathy induced neurodegeneration and can it be repaired? Neuropathol. Appl. Neurobiol. 28, 1-11 (2002).
52. M. Jeffrey, I. A. Goodbrand, and A. Goodsir, Pathology of the transmissible spongiform encephalopathies with special emphasis on ultrastructure. Micron 26, 277-298 (1995).
53. D. Jesionek-Kupnicka, J. Buczynski, R. Kordek, T. Sobow, I. Kloszewska, W. Papierz, and P. P. Liberski, Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease. Folia Neuropathol. 35, 233-235 (1997).
54. D. Jesionek-Kupnicka, R. Kordek, J. Buczynski, and P. P. Liberski, Apoptosis in relation to neuronal loss in experimental Creutzfeldt-Jakob disease in mice. Acta Neurobiol. Exp. 61, 13-19 (2001).
55. A. Dorandeu, L. Wingertsmann, F. Chretien, M-B. Delisle, C. Vital, P. Parchi, P. Montagna, E. Lugaresi, J. W. Ironside, H. Budka, P. Gambetti, and F. Gray, Neuronal apoptosis in fatal familial insomnia. Brain Pathol. 8, 531-537 (1998).
56. P. P. Liberski, R. Yanagihara, C. J. Gibbs Jr, and D. C. Gajdusek, Neuronal autophagic vacuoles in experimental scrapie and Creutzfeldt-Jakob disease. Acta Neuropathol. 83, 134-139 (1992).
57. J. W. Boellaard, M. Kao, W. Schlote, and H. Diringer, Neuronal autophagy in experimental scrapie. Acta Neuropathol. 82, 225-228 (1991).
58. J. W. Boellaard, W. Schlote, and J. Tateishi, Neuronal autophagy in experimental Creutzfeldt-Jakob disease. Acta Neuropathol. 78, 410-418 (1989).
59. B. Sikorska, P. P. Liberski, P. Giraud, N. Kopp, and P. Brown, Autophagy is a part of ultrastructural synaptic pathology in Creutzfeldt-Jakob disease: a brain biopsy study. Int. J. Biochem Cell Biol., in press (2004).
60. S. J. DeArmond, S.-L. Yang, A. Lee, R. Bowler, A. Taraboulos, D. Groth, and S. B. Prusiner, Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc. Natl. Acad. Sci., USA 90, 6449-6453 (1993).
61. P. P. Liberski, B. Sikorska, J. Bratosiewicz-Wasik, D. Carleton Gajdusek, and P. Brown, Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: from apoptosis to autophagy-a review. Int. J. Biochem Cell Biol., in press (2004).
62. P. P. Liberski, R. Yanagihara, C. J. Gibbs Jr, and D. C. Gajdusek, Tubulovesicular structures in experimental Creutzfeldt-Jakob disease and scrapie. Intervirology 29, 115-120 (1988).
63. P. P. Liberski and H. Budka, Tubulovesicular structures in Gerstmann-Sträussler-Scheinker disease. Acta Neuropathol. (Berl.) 88, 491-492 (1994).
64. M. Jeffrey, J. R. Fraser, Tubulovesicular particles occur early in the incubation period of murine scrapie. Acta Neuropathol. (Berl.) 99, 525-528 (2000).
65. P. H. Gibson and L. A. Doughty, An electron microscopic study of inclusion bodies in synaptic terminals of scrapie-infected animals. Acta Neuropathol. (Berl.) 77, 420-425 (1989).
66. J. F. David-Ferreira, K. L. David-Ferreira, C. J. Gibbs Jr., and J. A. Morris, Scrapie in mice: ultrastructural observations in the cerebral cortex. Proc. Soc. Exp. Biol. Med. 127, 313-320 (1968).
67. A. Bignami and H. B. Parry, Aggregations of 35-nanometer particle associated with neuronal cytopathic changes in natural scrapie. Science 171, 389-390 (1971).
68. P. P. Liberski, N. Streichenberger, P. Giraud, M. Soutrenon, D. Meyronnet, B. Sikorska, and N. Kopp, Ultrastructural pathology of prion diseases revisited: brain biopsy studies. Neuropathol. Appl. Neurobiol. in press (2005).
69. P. P. Liberski, R. Yanagihara, C. J. Gibbs Jr, and D. C. Gajdusek, Appearance of tubulovesicular structures in Creutzfeldt-Jakob disease and scrapie precedes the onset of clinical disease. Acta Neuropathol. (Berl.) 79, 1-9 (1989).
70. P. P. Liberski, M. Jeffrey, and C. Goodsir, Tubulovesicular structures are not labeled using antibodies to prion protein (PrP) with the immunogold electron microscopy techniques. Acta Neuropathol. (Berl.) 93, 260-264 (1997).
71. P. P. Liberski, M. Jeffrey, and C. Goodsir, Electron microscopy in prion research: tubulovesicular structures are not composed of prion protein (PrP) but may be intimately associated with PrP amyloid fibrils, in: Prions and brain diseases in animals and humans, edited by D. R. O. Morrison (Plenum Press, New York and London, 1998), pp. 77-86.
72. A. Tarabulos, K. Jendroska, D. Serban, S.-L. Yang, S. J. DeArmond, and S. B. Prusiner, Regional mapping of prion protein in brain. Proc. Natl. Acad. Sci., USA 89, 7620-7624 (1992).
73. W. J. Schulz-Schaeffer, S. Tschoke, N. Kranefuss, W. Drose, D. Hause-Reitner, A. Giese, M. H. Groschup, and H. A. Kretzschmar, The paraffin-embedded tissue blot detects PrPSc early in the incubation time in prion diseases. Am. J. Pathol. 156, 51-56 (2000).
74. C. Jarius, G. G. Kovacs, G. Belay, J. A. Hainfellner, E. Mitrova, and H. Budka, Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfedt-Jakob disease. Acta Neuropathol. 105, 449-454 (2003).
75. G. Kovacs, T. Voigtlander, J. A. Hainfellner, and H. Budka, Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases. Acta Neuropathol 104, 320-326 (2002).
76. G. G. Kovacs, E. Lindeck-Pozza, L. Chimelli, A. Q. C. Araujo, A. A. Gabbai, T. Strobel, M. Glatzel, A. Aguzzi, and H. Budka, Creutzfeldt-Jakob disease and inclusion body myisitis: abundant disease-associated prion protein in muscle. Ann. Neurol. 55, 121-125 (2004).
77. S. Haik, B. A. Faucheux, V. Sazdovitch, N. Privat, J.-L. Kemeny, A. Perret-Liaudet, and J.-J. Hauw, The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nature Med. 9, 1121-1123 (2003).
78. H. Budka, Histopathology and immunohistochemistry of human transmissible spongiform encephalopathies (TSEs). Arch. Virol. 16, 135-142 (2000).
79. D. C. Guiroy, S. K. Shankar, C. J. Gibbs Jr., J. A. Messenheimer, S. Das, and D. C. Gajdusek, Neuronal degeneration and neurfilament accumulation in the trigeminal ganglia in Creutzfeldt-Jakob disease. Ann. Neurol. 25, 102-106 (1989).
80. J. A. Hainfellner and H. Budka, Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies. Acta Neuropathol. 98, 458-460 (1999).
81. M. H. Groschup, M. Beekes, P. A. McBride, M. Hardt, J. A. Hainfellner, and H. Budka, Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie. Acta Neuropathol. 98, 453-457 (1999).
82. M. Glatzel, E. Abela, M. Maissen, and A. Aguzzi, Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 349, 1812-1820 (2003).
83. D. C. Gajdusek and V. Zigas, Degenerative disease of the central nervous system in New Guinea. The endemic occurrence of "kuru" in the native population. New Engl. J. Med. 257. 974-978 (1957).
84. I. Klatzo, D. C. Gajusek and V. Zigas, Evaluation of pathological findings in twelve cases of kuru, in: Encephalitides, edited by L. Van Boagert, J. Radermecker, J. Hozay, and A. Lowenthal (Elsevier Publ. Comp, Amsterdam, 1959), pp 172-190.
85. E. Beck and P. M. Daniel, Kuru and Creutzfeldt-Jakob disease: neuropathological lesions and their significance, in: Slow Transmissible Diseases of the Nervous System, edited by S. B. Prusiner and W. J. Hadlow (Academic Press, New York, 1979), Vol 1, pp. 253-270.
86. F. Seitelberger, Eigenartige familiar-hereditare Krankheit des Zetralnervensystems in einer niederosterreichischen Sippe. Wien Klin Wochen 74, 687-691 (1962).
87. M. A. Neuman, D. C. Gajdusek and V. Zigas, Neuropathologic findingsinexotic neurologic disorder among natives of the Highlands of New Guinea. J. Neuropathol. Exp. Neurol. 23. 486-507 (1964).
88. C. A. McLean, J. W. Ironside, M. P. Alpers, P. W. Brown, L. Cervenakova, R. M. D. Anderson, and C. L. Masters, Comparative neuropathology of kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol. 8, 428-437 (1998).
89. P. Piccardo, J. Safar, M. Ceroni, D. C. Gajdusek, C. J. Gibbs Jr, Immunohistochemical localization of prion protein in spongiform encephalopathies and normal brain tissue. Neurology 40, 518-522 (1990).
90. I. A. Goodbrand, J. W. Ironside, D. Nicolson, and J. E. Bell, Prion protein accumulations in the spinal cords of patients with sporadic and growth hormone-associated Creutzfeldt-Jakob disease. Neurosci. Lett. 183, 127-130 (1995).
91. A. von Braunmühl, Uber eine eigenartige hereditaer-familiaere Erkrankung des Zentralnervensystems. Arch. Psychiatr. Z. Neurol. 191, 419-449 (1954).
92. J. W. Boellaard and W. Schlote, Subakute spongiforme Encephalopathie mit multiformer Plaquebildung. Eigenartige familiar-hereditare Kranknheit des Zentralnervensystems [spino-cerebellare Atrophie mit Demenz, Plaques and plaqueahnlichen im Klein- and Grosshirn (Gerstmann, Sträussler, Scheinker). Acta Neuropathol. (Berl.) 49, 205-212 (1980).
93. K. Hsiao, H. F. Baker, T. J. Crow, M. Poulter, F. Owen, J. D. Terwilliger, D. Westaway, J. Ott, and S. B. Prusiner, Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 338, 342-345 (1989).
94. B. Ghetti, O. Bugiani, F. Tagliavini, and P. Piccardo, Prion disorders: Gerstmann-Sträussler-Scheinker disease, in Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, edited by D. Dickson (ISN Neuropath Press, Basel, 2003), pp. 318-325.
95. S. J. DeArmond, J. W. Ironside, E. Bouzamondo-Berstein, D. Peretz, and J. R. Fraser, Neuropathology of prion diseases, in: Prion Biology and Diseases, edited by S. B. Prusiner-2nd ed. (Cold Spring Harbor, New York, 2004), pp. 777-856.
96. P. P. Liberski, I. Kloszewska, I. Boellaard, W. Papierz, A. Omulecka, and H. Budka, Dystrophic neurites of Alzheimer's disease and Gerstmann- Sträussler-Scheinker's disease dissociate from the formation of paired helical filaments. Alzheimer's Res. 1, 89-93 (1995).
97. B. Ghetti, S. R. Dlouhy, G. Giaccone, O. Bugiani, B. Frangione, M. R. Farlow, and F. Tagliavini, Gerstmann-Sträussler-Scheinker diseases and the Indiana kindred. Brain Pathol. 5, 61-95 (1995).
98. J. W. Ironside, L. McCardle, A. Horsburgh, Z. Lim, and M. W. Head, Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 11, 79-87 (2002).
99. P. P. Liberski, J. Ironside, L. McCardle, A. Sherring, Ultrastructural analysis of the florid plaque in variant Creutzfeldt-Jakob disease. Folia Neuropathol. 38, 167-170 (2000).
100. J. G. Fournier, N. Kopp, N. Streichenberger, F. Escaig-Haye, J. Langeveld, and P. Brown, Electron microscopy of brain amyloid plaques from a patient with new variant Creutzfeldt-Jakob disease. Acta Neuropathol. 99, 637-642 (2000).
101. M. Zeidler, R. J. Sellar, D. A. Collie, R. Knight, G. Stewart, M. A. Macleod, J. W. Ironside, S. Cousens, A. C. Colchester, D. M. Hadley, R. G. Will, and A. F. Colchester, The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355, 1412-1418 (2000).
102. J. W. Ironside, K. Sutherland, J. E. Bell, L. McCardle, C. Barrie, K. Estebeiro, M. Zeidler, and R. G. Will, A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. Cold Spring Harb. Symp. Quant. Biol. 61, 523-530 (1996).
103. R. A. Armstrong, N. J. Cairns, J. W. Ironside, and P. L. Lantos, Quantification of vacuolation ("spongiform change"), surviving neurones and prion protein deposition in eleven cases of variant Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 28, 129-135 (2002).
104. R. A. Armstrong, N. J. Cairns, J. W. Ironside, and P. L. Lantos, Quantitative variations in the pathology of 11 cases of variant Creutzfeldt-Jakob disease (vCJD). Pathophysiology 8, 235-241 (2002).
105. R. A. Armstrong, N. J. Cairns, J. W. Ironside, and P. L. Lantos, The spatial patterns of prion protein deposits in cases of variant Creutzfeldt-Jakob disease. Acta Neuropathol. 104, 665-669 (2002).
106. W. H. Nailon and J. W. Ironside, Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis. Microsc. Res. Tech. 50, 2-9 (2000).
107. M. W. Head, V. Northcott, K. Rennison, D. Ritchie, L. McCardle, T. J. Bunn, N. F. McLennan, J. W. Ironside, A. B. Tullo, and R. E. Bonshek, Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease. Invest. Ophthalmol. Vis. Sci. 44, 342-346 (2003).
108. J. W. Ironside, M. W. Head, J. E. Bell, L. McCardle, and R. G. Will, Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 37, 1-9 (2000).
109. A. F. Hill, R. J. Butterworth, S. Joiner, G. Jackson, M. N. Rossor, D. J. Thomas, A. Frosh, N. Tolley, J. E. Bell, M. Spencer, A. King, S. Al-Sarraj, J. W. Ironside, P. L. Lantos, and J. Collinge, Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183-189 (1999).
110. S. Shimizu, K. Hoshi, T. Muramoto, M. Homma, J. W. Ironside, S. Kuzuhara, T. Sato, T. Yamamoto, and T. Kitamoto, Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch. Neurol. 56, 357-363 (1999).
111. P. Parchi, A. Giese, S. Capellari, P. Brown, W. Schulz-Schaeffer, O. Windl, I. Zerr, H. Budka, N. Kopp, P. Piccardo, S. Poser, A. Rojiani, N. Streichemberger, J. Julien, C. Vital, B. Ghetti, P. Gambetti, and H. Kretzschmar, Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46, 224-233 (1999).
112. G. Puoti, G. Giaccone, G. Rossi, B. Canciani, O. Bugiani, and F. Tagliavini, Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP (Sc) in the same brain. Neurology 53, 2173-2176 (1999).
113. C. A. Llewlyn, P. E. Hewitt, R. S. Knight, K. Amar, S. Cousens, J. Mackenzie, R. G. Will. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 417-421 (2004).
114. M. E. Bruce, R. G. Will, J. W. Ironside, I. McConnell, D. Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser, and C. J. Bostock, Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389, 498-501 (1997).
115. M. R. Scott, R. Will, J. Ironside, H. O. Nguyen, P. Tremblay, S. J. De Armond, and S. B. Prusiner, Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc. Natl. Acad. Sci. USA 96, 15137-15142 (1999).
116. S. Notari, S. Capellari, A. Giese, I. Westner, A. Baruzzi, B. Ghetti, P. Gambetti, H. A. Kretzschmar, and P. Parchi. Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J. Biol. Chem. 279, 16797-16804 (2004).